Cargando…
Serum Amyloid A Protein as a useful biomarker to predict COVID-19 patients severity and prognosis
Coronavirus Disease 2019 (COVID-19) can present with different grades of severity from mild to critical. Evaluation of biomarkers predicting severity is crucial to identify patients at high risk of disease progression and poor prognosis. Serum Amyloid A (SAA) is an acute-phase protein mainly produce...
Autores principales: | Pieri, Massimo, Ciotti, Marco, Nuccetelli, Marzia, Perrone, Marco Alfonso, Caliò, Maria Teresa, Lia, Maria Stella, Minieri, Marilena, Bernardini, Sergio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7923863/ https://www.ncbi.nlm.nih.gov/pubmed/33735714 http://dx.doi.org/10.1016/j.intimp.2021.107512 |
Ejemplares similares
-
The Antibodies’ Response to SARS-CoV-2 Vaccination: 1-Year Follow Up
por: Nicolai, Eleonora, et al.
Publicado: (2023) -
Evaluation of Hepcidin Level in COVID-19 Patients Admitted to the Intensive Care Unit
por: Ciotti, Marco, et al.
Publicado: (2022) -
SARS-CoV-2 infection serology: a useful tool to overcome lockdown?
por: Nuccetelli, Marzia, et al.
Publicado: (2020) -
Evaluation of a new simultaneous anti-SARS-CoV-2 IgA, IgM and IgG screening automated assay based on native inactivated virus
por: Nuccetelli, Marzia, et al.
Publicado: (2021) -
Antibody response to COVID-19 vaccine: A point of view that can help to optimize dose distribution
por: Pieri, Massimo, et al.
Publicado: (2022)